Real-world safety profile of therapy with ibrutinib or acalabrutinib in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma
伊布替尼或阿卡替尼治疗慢性淋巴细胞白血病/小淋巴细胞淋巴瘤患者的真实世界安全性概况
期刊:
影响因子:
doi:10.1016/j.bneo.2024.100064
Hafer, Ramsay; Iadevaia, Francesco; Rohan, Thomas Z; Duong, Teresa; Poluch, Maria; Keiffer, Gina; Li, Michael; Ferber, Andres; Laurenti, Luca; Khoo, Alan S; Porcu, Pierluigi